
Triglyceride-rich lipoproteins and their remnants: Commentary on the 2021 EAS Consensus Statement
The recent European Atherosclerosis Society Consensus Statement on triglyceride-rich lipoproteins (TRLs) and their remnants is the culmination of an 18-month wide-ranging review of the very complex relationship between elevated triglyceride levels and cardiovascular disease.1 Professor Gary Lewis, Director of the Banting and Best Diabetes Centre at the University of Toronto, Canada, and co-author of the report […]